Design, Synthesis, and Structure–Activity Relationship Study of μ-Conotoxin KIIIA toward Na V 1.4
- 31 March 2026
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (7) , 7856-7868
Abstract
NaV1.4 expressed in skeletal muscle, is a validated target for treating neuromuscular disorders. While the μ-conotoxin KIIIA is the one of the smallest conopeptide inhibitors of NaV1.4, its therapeutic potential is limited by potency and synthetic complexity. Using a computational model, we designed analogues with added positive charges, yielding [K7R, A15R]KIIIA-1 (IC50 = 20.5 nM). Further optimization produced [S5R]KA with high potency (IC50 = 5.1 nM) but poor enzymatic stability (t1/2 < 4 h). To improve stability, we replaced Cys4 with penicillamine (Pen), generating C4Pen. This analogue maintained excellent activity (IC50 = 11.1 nM) and significantly improved stability (t1/2 > 8 h), and both analogues preferentially inhibited NaV1.4 with moderate activity at NaV1.2 and NaV1.7 and exhibited no detectable inhibition of NaV1.5. In vivo studies confirmed that both [S5R]KA and C4Pen induce potent muscle relaxation. This structure-based optimization combines electrostatic mutagenesis with Pen-mediated stabilization, yielding a promising peptide therapeutic candidate.Keywords
Funding Information
- National Health and Medical Research Council (APP2014544)
- Qingdao National Laboratory for Marine Science and Technology (2022QNLM030003)
- Major Scientific and Technological Innovation Project of Shandong Province (2022CXGC020414)
- Fundamental Research Funds for the Central Universities (202441004)
- National Natural Science Foundation of China (22201164)
- National Natural Science Foundation of China (32171267)
- National Natural Science Foundation of China (82122064)
- Jinan Innovation Team Project (202333022)
- Qingdao Marine Biomedical Research Institute, Ocean University of China (YZ1-25-04)
This publication has 52 references indexed in Scilit:
- Design, synthesis, and mechanism of action of novel μ-conotoxin KIIIA analogues for inhibition of the voltage-gated sodium channel Nav1.7Journal of Biological Chemistry, 2023
- Structure and Function of Sodium Channel Nav1.3 in Neurological DisordersCellular and Molecular Neurobiology, 2022
- Structural and functional insights into the inhibition of human voltage-gated sodium channels by μ-conotoxin KIIIA disulfide isomersJournal of Biological Chemistry, 2022
- Differences in local anaesthetic and antiepileptic binding in the inactivated state of human sodium channel Nav1.4Biophysical Journal, 2021
- Structural Pharmacology of Voltage-Gated Sodium ChannelsJournal of Molecular Biology, 2021
- Synthesis of Disulfide Surrogate Peptides Incorporating Large‐Span Surrogate Bridges Through a Native‐Chemical‐Ligation‐Assisted Diaminodiacid StrategyAngewandte Chemie International Edition, 2020
- Structure of the Nav1.4-β1 Complex from Electric EelCell, 2017
- Solid Phase Protein Chemical Synthesis2014
- Structurally Minimized μ‐Conotoxin Analogues as Sodium Channel Blockers: Implications for Designing Conopeptide‐Based TherapeuticsChemMedChem, 2009
- Sodium Channels and Mechanisms of Neuropathic PainThe Journal of Pain, 2006